Retrospective analysis shows growing concentrations in radiology and computed tomography within China’s regulatory framework.
China's AIMD ecosystem is experiencing growth, heavily focused on radiology and computed tomography-based solutions within a risk-proportionate regulatory framework. The market is characterized by significant manufacturer and geographic concentration.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: